Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 2
2021 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort.
Rhiem K, Bücker-Nott HJ, Hellmich M, Fischer H, Ataseven B, Dittmer-Grabowski C, Latos K, Pelzer V, Seifert M, Schmidt A, Rezek D, Groh U, Meinerz W, Crommelinck D, Hahnen E, Wesselmann S, Schmutzler RK. Rhiem K, et al. Among authors: dittmer grabowski c. Breast J. 2019 May;25(3):455-460. doi: 10.1111/tbj.13257. Epub 2019 Apr 5. Breast J. 2019. PMID: 30953388
Using a New Marker Clip System in Breast Cancer: Tumark Vision® Clip - Feasibility Testing in Everyday Clinical Practice.
Rüland AM, Hagemann F, Reinisch M, Holtschmidt J, Kümmel A, Dittmer-Grabowski C, Stöblen F, Rotthaus H, Dreesmann V, Blohmer JU, Kümmel S. Rüland AM, et al. Among authors: dittmer grabowski c. Breast Care (Basel). 2018 Apr;13(2):116-120. doi: 10.1159/000486388. Epub 2018 Mar 9. Breast Care (Basel). 2018. PMID: 29887788 Free PMC article.
Updated Survival Analysis after a Median Follow-up of 12 Years of an Anthracycline-Containing Adjuvant Prospective Multicentre, Randomised Phase III Trial on Dose-Dense Chemotherapy in Primary Node-Positive, High-Risk Breast Cancer Patients.
Reinisch M, Gluz O, Ataseven B, Blohmer JU, Budner M, Dittmer-Grabowski C, Kohls A, Krocker J, Kümmel A, Hagemann F, Rüland A, Traut A, Kümmel S. Reinisch M, et al. Among authors: dittmer grabowski c. Breast Care (Basel). 2019 Jun;14(3):159-164. doi: 10.1159/000491792. Epub 2018 Sep 5. Breast Care (Basel). 2019. PMID: 31316314 Free PMC article.
Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy.
Reinisch M, Bruzas S, Gluz O, Ataseven B, Schmid P, Cortés J, Blohmer JU, Shenoy S, Dyson MH, Dittmer-Grabowski C, Chiari O, Harrach H, Gebauer D, Traut A, Kuemmel S. Reinisch M, et al. Among authors: dittmer grabowski c. Mol Oncol. 2023 Jun;17(6):1060-1075. doi: 10.1002/1878-0261.13435. Epub 2023 Apr 24. Mol Oncol. 2023. PMID: 37057719 Free PMC article.